4//SEC Filing
Guiheen Lawrence P. 4
Accession 0001140361-25-020376
CIK 0001368514other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 9:00 PM ET
Size
15.2 KB
Accession
0001140361-25-020376
Insider Transaction Report
Form 4
Guiheen Lawrence P.
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-05-21−7,779→ 1,221 totalExercise: $5.96Exp: 2026-01-28→ Common Stock (7,779 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-05-22−1,221→ 0 totalExercise: $5.96Exp: 2026-01-28→ Common Stock (1,221 underlying) - Sale
Common Stock
2025-05-22$20.12/sh−1,221$24,567→ 114,830 total - Sale
Common Stock
2025-05-21$20.32/sh−7,779$158,069→ 114,830 total - Exercise/Conversion
Common Stock
2025-05-22$5.96/sh+1,221$7,277→ 116,051 total - Exercise/Conversion
Common Stock
2025-05-21$5.96/sh+7,779$46,363→ 122,609 total
Holdings
- 50,990(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.73. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F2]Includes, as of the transaction date, (i) 10,889 restricted stock units granted on February 19, 2025, which vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of such vesting date; and (ii) 103,941 shares of common stock owned by the Reporting Person. The number of common shares reported includes a de minimis reduction by 10 shares from the amount previously reported due to a broker adjustment.
- [F3]Includes 50,990 shares of common stock held in the Lawrence P Guiheen Irrevocable Trust 1 (the "Guiheen Irrevocable Trust"), of which 49,990 shares were inadvertently reported in prior reports as directly owned.
- [F4]These shares are owned by the Guiheen Irrevocable Trust.
- [F5]The Reporting Person is exercising this option due, in part, to its near-term expiration date.
- [F6]These options were granted on January 28, 2016 and vested in twenty-four equal monthly installments, becoming fully vested on January 28, 2018.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
Related Parties
1- filerCIK 0001554353
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 9:00 PM ET
- Size
- 15.2 KB